How Is Ozempic Administered for Weight Loss?

Last reviewed: June 15, 2026

Last updated: June 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist that slows stomach emptying and activates brain centers controlling hunger, leading to an average weight loss of 10–15% over 68 weeks in clinical trials. Understanding how to properly administer semaglutide injections is essential for achieving consistent results and tolerating the medication safely. PlexusDx offers compounded semaglutide from licensed 503A pharmacies, giving patients a straightforward path to personalized weight loss therapy.

How Semaglutide Injections Are Administered for Weight Loss

Semaglutide injections are given as a subcutaneous (under-the-skin) dose once per week, typically on the same day each week. Patients self-administer the injection using a pre-filled pen device into the abdomen, thigh, or upper arm—sites that are easy to access and rotate to avoid skin irritation. The needle is short and thin, designed to reach the fatty tissue layer below the skin without entering muscle, making the injection relatively painless for most patients.

The administration process takes less than one minute. After choosing an injection site, patients clean the area with an alcohol wipe, pinch the skin gently, insert the needle at a 90-degree angle, and press the plunger to deliver the medication. Once the dose is complete, the needle is withdrawn and the site may be covered with a small bandage if needed. PlexusDx provides detailed injection training materials and video guides to ensure patients feel confident administering their weekly doses at home.

Weekly Dosing Schedule and Titration for Semaglutide

Semaglutide treatment begins with a low starting dose to allow the body to adapt and minimize side effects, then increases gradually over weeks or months based on patient tolerance and clinical response. A typical titration schedule starts at 0.25 mg weekly for four weeks, increases to 0.5 mg for four weeks, then moves to 1.0 mg weekly, with further increases possible up to 2.4 mg depending on individual needs. This gradual approach helps patients experience appetite suppression benefits while reducing the severity of gastrointestinal adjustment symptoms like nausea.

PlexusDx offers compounded semaglutide injections starting at $149 per month, with your dose adjusting as your clinical progress unfolds—but your monthly price remains flat regardless of dose level. This pricing model removes the guesswork around medication costs and ensures patients can focus on their treatment goals rather than worrying about escalating fees. Regular check-ins with PlexusDx clinical staff help monitor response and safety, allowing dose adjustments to be made whenever needed.

Storage and Preparation of Compounded Semaglutide Pens

Compounded semaglutide from PlexusDx arrives in pre-filled injection pens that must be stored in the refrigerator between 36°F and 46°F (2°C to 8°C) until first use. Once you begin using a pen, it can be kept at room temperature (up to 77°F or 25°C) for up to 28 days, making it convenient for travel or daily life. Never expose semaglutide to direct sunlight, extreme heat, or freezing temperatures, as these can degrade the medication and reduce its effectiveness.

Before each injection, inspect the pen to ensure the solution is clear and colorless—if it appears cloudy, discolored, or contains particles, do not use it and contact PlexusDx for a replacement. Allow the pen to reach room temperature for 15–30 minutes before injecting if it comes straight from the refrigerator, as cold medication may cause mild discomfort. Keep all pens out of reach of children and pets, and dispose of used needles in a sharps container rather than regular trash.

What to Expect During Your First Semaglutide Injection Week

Many patients notice reduced appetite and increased fullness within 24–48 hours of their first semaglutide injection, though the appetite-suppressing effect continues to build over the first four weeks of treatment. Some experience mild nausea, constipation, or fatigue during the first few days as the body adjusts to the medication; these side effects typically fade within one to two weeks. Staying well-hydrated, eating smaller meals more slowly, and including high-fiber foods can help minimize gastrointestinal discomfort and support the body's adaptation.

Weight loss patterns vary between individuals, with some seeing measurable progress within two to four weeks and others taking six to eight weeks to observe significant changes. PlexusDx Precision Peptide Genetic Testing can identify your unique peptide-pathway profile, revealing how your body may respond to GLP-1 therapy based on genetic variants in pathways like GLP1R and FTO. This genetic insight helps tailor your semaglutide strategy and set realistic expectations for timing and magnitude of weight loss.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide myself at home, or do I need a healthcare provider to administer it?

You can safely inject semaglutide yourself at home after a brief training session. PlexusDx provides step-by-step instruction materials and video guides showing exactly how to prepare the injection site, hold the pen, and administer the dose. Most patients become comfortable with self-injection within one or two attempts.

What is the clinical evidence for semaglutide's weight loss effectiveness?

In the STEP clinical trials, patients taking semaglutide 2.4 mg weekly achieved an average weight loss of 14–15% of body weight over 68 weeks, compared to roughly 2.4% in the placebo group. Many patients also experienced improvements in blood sugar control, blood pressure, and cholesterol levels, with benefits persisting as long as the medication was continued.

How much does compounded semaglutide cost at PlexusDx, and is it covered by insurance?

PlexusDx compounded semaglutide injections start at $149 per month and are available without insurance or membership requirements. The service is HSA/FSA eligible, and pricing stays flat regardless of dose adjustments, meaning your monthly cost won't increase as your dose is optimized over time.

What are the most common side effects of semaglutide injections?

Nausea is the most frequently reported side effect, especially during the first two weeks of treatment or after a dose increase, but usually improves with time. Other common effects include constipation, fatigue, and mild diarrhea; serious side effects are rare and most often appear in people with personal or family histories of thyroid cancer or pancreatitis. Inform your PlexusDx clinical team about any pre-existing health conditions so they can monitor your safety.

How does the PlexusDx Precision Peptide Genetic Test help with semaglutide therapy?

PlexusDx Precision Peptide Genetic Testing examines 14 pathways and 49 peptides, including key GLP-1 pathway variants, to reveal how your genetics may influence your response to semaglutide and other GLP-1 medications. This $99 add-on test helps personalize your treatment plan and predict whether you may be a strong responder or require additional therapies for optimal results.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.